Ann Geriatr Med Res Search

CLOSE


Ann Geriatr Med Res > Volume 28(3); 2024 > Article
Olcay, Emektar, Öztürk, Akkan, and Çevik: Association of Serum Lactate Levels Measured in the Emergency Department with 30-Day Mortality in Older Patients with Unilateral Hip Fractures

Abstract

Background

Hip fractures are frequent injuries in older patients and are associated with high mortality rates. This study assessed the association between serum lactate level and 30-day mortality in older patients with unilateral hip fractures and examined the prognostic value of this association on the clinical outcomes of these patients.

Methods

This retrospective, single-center study included patients aged ≥65 years admitted to the emergency department due to low-energy trauma and diagnosed with unilateral hip fracture upon admission. The additional inclusion criteria were patients with independent ambulation or walker or cane assistance before the injury, with available data on serum lactate levels on venous blood gas analysis, and who underwent surgery.

Results

Among the 330 included patients, 30.9% experienced postoperative complications and 10.3% died within 30 days. Using a lactate cut-off value of 2 mmol/L to distinguish between living and deceased patients, the sensitivity and specificity were 41% and 88%, respectively. Multivariate logistic regression analysis revealed that high lactate and low albumin levels and male sex were associated with mortality.

Conclusion

Identifying risk factors for mortality in geriatric patients with hip fractures is important. Male sex, low albumin levels, and particularly increased lactate levels were independent predictors of short-term mortality in these patients.

INTRODUCTION

The older adult population has been increasing in developed countries in recent years due to prolonged lifespans.1) Hip fractures are a common injury among this population, and can lead to increased morbidity and mortality due to factors such as limited physiologic reserve, preoperative medical conditions, and major surgery.2) Approximately 1.6 million individuals experience hip fractures worldwide annually.3) These injuries usually result from low-energy trauma and present significant challenges to patients and their families. Factors such as rehabilitation processes and long-term care needs can affect cost and quality of life. Older patients treated for hip fractures have a shorter average survival time than those without.1,3) In this context, assessing the risk of mortality and morbidity in patients with hip fractures and identifying factors that may increase the chance of recovery is important.4)
Lactate is a commonly used marker for conditions such as cellular oxygen deficiency and circulatory disorders. Studies in recent years have investigated the relationship between lactate levels and clinical outcomes of patients. Blood gas analysis is a low-cost and easily accessible test, particularly in emergency services.5,6) Recent studies have demonstrated the value of lactate level as a prognostic indicator for evaluating trauma severity and predicting the prognosis of patients with multiple traumas.5-7) However, few studies have reported on lactate levels and trauma in geriatric patient groups.
Therefore, this study assessed the correlation between serum lactate levels and 30-day mortality in older patients with unilateral hip fractures and determined the potential prognostic value of this association in the clinical outcomes of these patients.

MATERIALS AND METHODS

Study Design

This retrospective study was conducted in an emergency department with an annual average of 385,000 patient visits. After receiving approval from Ataturk Sanatoryum Training and Research Hospital Ethics Committee (No. 2012-KAEK-15/2843), data were collected from electronic health records and patient files. Also, this study complied with the ethical guidelines for authorship and publishing in the Annals of Geriatric Medicine and Research.8)

Study Population

The study included patients diagnosed with unilateral hip fractures in the emergency department between January 10, 2020, and January 10, 2023. We used the hospital data system to identify patients with International Classification of Diseases, 10th revision (ICD-10) codes S72.00, S72.10, and S72.20. We included patients who experienced low-energy trauma (a fall from a level at or below body height), were able to walk independently or with the aid of a walker or cane before the injury, were aged ≥65 years, had available data on serum lactate levels measured during the emergency department evaluation, and who underwent surgery. We excluded patients who were <65 years of age, unable to care for themselves before the injury, had additional injuries other than hip fractures, were in the high-risk group (American Society of Anesthesiologists [ASA] grade V), had high-energy trauma, and had not undergone surgery.
The fracture diagnoses and types were determined using pelvis/hip radiography and/or pelvic computed tomography. We classified the fracture types as femoral neck, pertrochanteric, and subtrochanteric fracture.9) An additional inclusion criterion was patients who had venous blood samples taken within the first hour of admission to the emergency department. The blood gas samples were analyzed using a Siemens RAPIDLab 1265 device (Siemens Healthineers, Erlangen, Germany) within 5 minutes of collection.
This study analyzed demographic data, comorbidities, medications, laboratory results, postoperative complications, and 30-day mortality. We classified postoperative complications according to the POSSUM (physiological and operative severity score for enumeration of mortality and morbidity) score10) and included fever, pulmonary infection, wound infection, urinary tract infection, septicemia, heart failure, acute renal failure, arrhythmia, myocardial infarction, deep vein thrombosis, pulmonary embolism, and ischemic stroke. The primary and secondary outcomes of this study were 30-day mortality and postoperative complications, respectively.

Data Analysis

We performed the data analysis using IBM SPSS Statistics for Windows, version 20.0 (IBM Corp., Armonk, NY, USA). The Kolmogorov–Smirnov test was used to determine the normality of the distributions of discrete and continuous numerical variables. Descriptive statistics include medians and interquartile range (IQR) for discrete and continuous numerical variables, and the number of cases and percentages for categorical variables. We evaluated categorical and continuous variables using the chi-square and Mann–Whitney U tests, respectively. We applied univariate tests to evaluate mortality predictors and included statistically significant variables (p<0.2) in a multivariate logistic regression model. The Hosmer–Lemeshow test was used to evaluate the fit of the multivariate regression model. We performed receiver operating characteristic (ROC) analysis and calculated the area under the curve (AUC) to determine the cut-off lactate level to distinguish between mortality and intensive care unit complications. Statistical significance was set at p<0.05.

RESULTS

During the study period, we evaluated 579 patients diagnosed with hip fracture. Of these, we included 330 patients with complete data (Fig. 1). Most patients were female (64.5%), and the median age was 81 years (IQR, 75–87). The median lactate level was 1.26 mmol/L (IQR, 0.9–1.76). The most common fracture type was pertrochanteric (58.5%). Postoperative complications occurred in 30.9% of patients, with fever the most common complication (19.4%). The 30-day mortality was 10.3%. Demographic, laboratory, and clinical data and patient outcomes are shown in Table 1.
Table 2 shows the results of the comparison between patients who did and did not die within 30 days. Advanced age, a history of hypertension, high lactate levels, and low albumin levels were significant factors associated with mortality (p<0.05). Additionally, postoperative complications and prolonged hospital stay were associated with mortality (p<0.05). Mortality did not differ significantly according to the type of fracture or surgery performed (p>0.05).
The results of the ROC analysis identified that a lactate level cut-off value of 2 mmol/L was differentiated between deceased and living patients with an AUC value of 0.712 (95% confidence interval [CI], 0.615–0.810) (Fig. 2) and a sensitivity and specificity of 41% and 88%, respectively. The lactate levels of patients who did and did not develop postoperative complications differed significantly (1.71 mmol [1.2–2.5] vs. 1.1 mmol [0.8–1.4], p<0.001). The ROC analysis to determine the lactate level threshold between patients with and without postoperative complications revealed an AUC of 0.744 (95% CI, 0.684–0.804) for a threshold of 2.1 mmol/L, with sensitivity and specificity of 31% and 96%, respectively (Fig. 3).
Multivariate logistic regression analysis was performed to examine the effects of the variables analyzed in Table 2 and lactate levels, together with other variables, on mortality. In the multivariate model, hypertension, dementia, lactate, and albumin levels (p≤0.2), as well as age, and sex were included. The results of the Hosmer–Lemeshow test demonstrated the fitness of the model, and the association of high lactate level, low albumin level, and male sex with mortality (p=0.043, p=0.001, and p=0.003, respectively) (Table 3).

DISCUSSION

The results of our study demonstrated the value of serum lactate level as a prognostic indicator in older patients with isolated hip fractures. Moreover, lactate levels >2 mmol/L were associated with 30-day mortality and the risk of postoperative complications. In addition, older age, male sex, and low albumin levels were associated with 30-day mortality. Therefore, a lactate concentration of ≥2 mmol/L can be used as a biomarker to predict the short-term risk of death in older patients after hip fracture surgery. This biomarker may assist clinicians in the early identification of critically ill patients and the prediction of outcomes and management.
Hip fractures are a common consequence of the growing older adult population and the global osteoporosis epidemic. These fractures are associated with high morbidity and mortality. The reported 1-month, 6-month, and 1-year mortality rates are approximately 11%, 16%, and 35%, respectively.11-14) We also analyzed the demographic, laboratory, and clinical characteristics of the patients, especially the blood lactate level, to define the conditions associated with mortality and morbidity in hip fractures, which have a high incidence and mortality rate. In our study, the 30-day mortality rate was 10.3%, similar to that reported in the literature. Although our study was limited to a patient population selected according to specific criteria, the similarity of mortality rates to those in the literature suggests that our data have general validity.
Lactate levels generally increase during trauma due to conditions such as tissue hypoperfusion, anaerobic metabolism, cellular damage, inflammation, mitochondrial dysfunction, and systemic inflammation that occur because of inadequate oxygen transport to tissues and impaired energy production processes. Recent studies have highlighted the clinical importance of lactate in shock, especially in patients with trauma, and have demonstrated the prognostic value of this biomarker.6,7,15) High lactate levels are also associated with mortality in hip fractures, especially in geriatric patients. One study reported that a lactate concentration of >2 mmol/L measured at the time of the patient’s initial presentation was a good prognostic indicator of 30-day mortality.15) In the present study, the sensitivity and specificity values for a lactate concentration of >2 mmol/L were 41% and 88%, respectively, to differentiate between living and deceased patients based on previous studies.9,14-17) The sensitivity and specificity values using a lactate cut-off value of 2.1 mmol/L for predicting the development of postoperative complications, were 31% and 96%, respectively. In the multivariate regression analysis, high lactate levels were associated with mortality. Our results showed that lactate levels >2 mmol/L were associated with a significant increase in the risks of mortality and complications. However, low lactate levels did not completely exclude these risks. This may be due to factors such as patient comorbidities, individual differences in lactate clearance, margin of error in laboratory testing, and the time elapsed between trauma and hospital arrival.
Another study reported a significant difference in 30-day mortality rates between patients with lactate levels <3 mmol/L and >3 mmol/L (6.8% vs. 28%).14) Moreover, lactate levels >1.2 mmol/L and pH <7.35 measured just before surgery in patients with hip fractures, are associated with 90-day mortality, as well as worsening hypovolemia, anemia, or decreased cardiac output while awaiting surgery.18) In a study by Jonsson et al.9) using the 2 mmol/L threshold for lactate in a similar patient population, lactate was not predictive of 30-day mortality and postoperative complications. The author suggested that high lactate levels may be secondary to factors other than trauma-induced hypoperfusion and factors other than tissue hypoxia may be more important for outcomes in older patients with hip fracture. Although conflicting opinions are reported in the literature, various studies have demonstrated the association of high lactate levels with mortality and morbidity in patients with isolated hip fractures. The use of a specific lactate cutoff for mortality prediction has significant potential in clinical settings; however, a comprehensive view of its efficacy across different clinical settings and patient demographics is imperative. Factors such as age, sex, comorbidities, and treatment history can significantly alter the impact of lactate level on mortality prediction. The results of the present study may catalyze further investigation to determine whether a specific lactate cutoff value should be universally considered as a tool for mortality prediction.
In geriatric patients with trauma, the risk of mortality is higher in men and with increasing age.19-22) The results of our regression analysis for mortality, in addition to similar predictors, revealed the significant association of high lactate levels with mortality. In addition, lactate levels at admission were significantly higher in patients who developed postoperative complications than in those who did not. Thus, patients with high lactate levels should be monitored closely during the postoperative period and carefully managed for potential complications
Our study has various limitations. First, this was a retrospective and single-center study, and the results cannot be generalized to other centers. We included patients whose lactate levels were measured within the first hour of admission to the emergency department. However, the time between presenting to the emergency department and experiencing trauma varies among patients, which may impact lactate levels and, thus, the study results. Because lactate levels were not measured in all patients with hip fractures, not all patients were included in the study. However, the patients in our study had demographic characteristics similar to those in other studies.9,14,16,17)
In conclusion, identifying risk factors for mortality in geriatric patients with hip fractures is important. Our study results showed that in older patients with isolated hip fractures, a serum lactate level of >2 mmol/L was associated with 30-day mortality and the risk of postoperative complications. Male sex, low albumin levels, and particularly increased lactate levels were independent predictors of short-term mortality in geriatric patients with isolated hip fractures.

ACKNOWLEDGMENTS

CONFLICT OF INTEREST

The researchers claim no conflicts of interest.

FUNDING

None.

AUTHOR CONTRIBUTIONS

Conceptualization, HOO, EE; Data curation, HOO, EE; Investigation, HOO, ZSO, SA; Methodology, HOO, EE, YC; Project administration, YC; Supervision, EE, YC; Writing-original draft, HOO, EE; Writing-review & editing, HOO, EE.

Fig. 1.
Flowchart showing number of patients of the study.
agmr-24-0011f1.jpg
Fig. 2.
Receiver operating characteristic curve analysis to determine lactate threshold between deceased and living patient groups.
agmr-24-0011f2.jpg
Fig. 3.
Receiver operating characteristic curve analysis to determine lactate threshold between patient groups with and without postoperative complications.
agmr-24-0011f3.jpg
Table 1.
Demographics and some laboratory findings of the patients
Characteristic Value
Age (y) 81 (75–87)
Sex, female 213 (64.5)
Comorbidities
 Hypertension 276 (83.6)
 Diabetes mellitus 130 (39.4)
 CAD/heart failure 120 (36.4)
 COPD 76 (23)
 Dementia 60 (18.2)
 Atrial fibrillation 48 (14.5)
 Chronic renal disease 34 (10.3)
 Anticoagulation drug use 32 (9.7)
Lactate (mmol/L) 1.26 (0.9–1.76)
pH 7.41 (7.36–7.43)
Hemoglobin (g/dL) 12.2(10.8–13.6)
Glucose (mg/dL) 135 (113–168.5)
Urea (mg/dL) 45 (36–58.2)
Creatinine (mg/dL) 1 (0.8–1.22)
Albumin (g/dL) 36.2 (33.2–38.6)
Type of fracture
 Neck 122 (37)
 Pertrochanteric 193 (58.5)
 Subtrochanteric 15 (4.5)
Anesthesia
 ASA PS-2 66 (20)
 ASA PS-3 237 (71.8)
 ASA PS-4 27 (8.2)
Postoperative complications 102 (30.9)
 Fever 64 (19.4)
 Chest infection 41 (12.4)
 Acute renal failure 32 (9.7)
 Cardiac failure 29 (8.8)
 Sepsis 25 (7.6)
 Arrhythmia 23 (7)
 Urinary infection 20 (6.1)
 Myocardial infarction 12 (3.6)
 Wound infection 10 (3)
 Deep venous thrombosis/pulmonary embolism 9 (2.7)
 Ischemic stroke 2 (0.6)
Length of hospital stay (day) 5 (3–6.2)
30 days mortality 34 (10.3)

Values are presented as median (interquartile range) or number (%).

CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; ASA PS, American Society of Anesthesiologists physical status classification.

Table 2.
Patients’ characteristics according to 30 days mortality
Survivor Non-survivor p-value
Age (y) 81 (74–86) 84.5(78–88) 0.023
Sex, female 196 (66.2) 17 (50) 0.061
Comorbidities
 Hypertension 243 (82.1) 33 (97.1) 0.025
 Diabetes mellitus 120 (40.5) 10 (29.4) 0.208
 CAD/heart failure 106 (35.8) 14 (41.2) 0.538
 COPD 69 (23.3) 7 (20.6) 0.721
 Dementia 50 (16.9) 10 (29.4) 0.073
 Atrial fibrillation 41 (13.9) 7 (20.6) 0.304
 Chronic renal disease 32 (10.8) 2 (5.9) 0.553
 Anticoagulation drug use 27 (9.1) 5 (14.7) 0.352
Lactate (mmol/L) 1.23 (0.9–1.69) 1.77 (1.36–2.62) <0.001
pH 7.41 (7.36–7.43) 7.41 (7.34–7.43) 0.508
Hemoglobin (g/dL) 12.2 (10.8–13.6) 12.4 (10.8–14) 0.611
Glucose (mg/dL) 135 (114–167.7) 150 (110–175.7) 0.66
Urea (mg/dL) 45 (36–59) 42 (33–57.2) 0.664
Creatinine (mg/dL) 1 (0.8–1.22) 0.97 (0.81–1.23) 0.885
Albumin (g/dL) 36.5 (33.9–38.9) 33.6 (31–36.4) <0.001
Postoperative complications 79 (27.6) 23 (69.7) <0.001
Type of fracture
 Neck 111 (37.5) 11 (32.4)
 Intertrochanteric 172 (58.1) 21 (61.8) 0.804
 Subtrochanteric 13 (4.4) 2 (5.9)
Anesthesia
 ASA PS-2 64 (22.4) 3 (9.1)
 ASA PS-3 202 (70.6) 24 (72.7) 0.035
 ASA PS-4 20 (7) 6 (18.2)
Length of hospital stay (day) 5 (3–6) 8 (4–15.5) 0.001
Length of ICU stay (day) 1 (1–2) 5 (1–12) <0.001

Values are presented as median (interquartile range) or number (%).

CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; ASA PS, American Society of Anesthesiologists physical status classification; ICU, intensive care unit.

Table 3.
Multivariate regression model to predict mortality
Wald p-value HR (95% CI)
Age 1.579 0.209 1.035 (0.981–1.092)
Sex 4.084 0.043 2.217 (1.024 – 4.796)
Hypertension 2.576 0.108 5.347 (0.690–41.420)
Dementia 2.356 0.125 2.003 (0.825–4.863)
Lactate 11.934 <0.001 1.829 (1.299–2.577)
Albumin 8.710 0.003 0.874 (0.799–0.956)

HR, hazard ratio; CI, confidence interval.

REFERENCES

1. Takeda K, Wada M, Yorozuya K, Hara Y, Watanabe T, Hanaoka H. Factors associated with improvement in activities of daily living during hospitalization: a retrospective study of older patients with hip fractures. Ann Geriatr Med Res 2023;27:220–7.
crossref pmid pmc pdf
2. Emektar E, Dagar S, Uzunosmanoglu H, Karaaslan F, Corbacioglu SK, Cevik Y. Etiology and prevalence of hyponatremia in geriatric patients with fragility hip fractures. Ann Clin Anal Med 2021;12:162–6.
crossref
3. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726–33.
crossref pmid pdf
4. Jang BW, Kim JW, Nho JH, Lee YK, Park JW, Cha YH, et al. Hip fractures in centenarians: functional outcomes, mortality, and risk factors from a multicenter cohort study. Clin Orthop Surg 2023;15:910–6.
crossref pmid pmc pdf
5. Baxter J, Cranfield KR, Clark G, Harris T, Bloom B, Gray AJ. Do lactate levels in the emergency department predict outcome in adult trauma patients?: a systematic review. J Trauma Acute Care Surg 2016;81:555–66.
crossref pmid
6. Zadorozny EV, Weigel T, Stone A, Gruen DS, Galvagno SM Jr, Yazer MH, et al. Prehospital lactate is associated with the need for blood in trauma. Prehosp Emerg Care 2022;26:590–9.
crossref pmid
7. Raux M, Le Manach Y, Gauss T, Baumgarten R, Hamada S, Harrois A, et al. Comparison of the prognostic significance of initial blood lactate and base deficit in trauma patients. Anesthesiology 2017;126:522–33.
crossref pmid pdf
8. Noh JH, Jung HW, Ga H, Lim JY. Ethical guidelines for publishing in the Annals of Geriatric Medicine and Research. Ann Geriatr Med Res 2022;26:1–3.
crossref pmid pmc pdf
9. Jonsson MH, Hommel A, Turkiewicz A, Ekelund U, Melander O, Englund M, et al. Plasma lactate at admission does not predict mortality and complications in hip fracture patients: a prospective observational study. Scand J Clin Lab Invest 2018;78:508–14.
crossref pmid
10. Wang TJ, Zhang BH, Gu GS. Evaluation of POSSUM scoring system in the treatment of osteoporotic fracture of the hip in elder patients. Chin J Traumatol 2008;11:89–93.
crossref pmid
11. Hu F, Jiang C, Shen J, Tang P, Wang Y. Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis. Injury 2012;43:676–85.
crossref pmid
12. Wu TY, Jen MH, Bottle A, Liaw CK, Aylin P, Majeed A. Admission rates and in-hospital mortality for hip fractures in England 1998 to 2009: time trends study. J Public Health (Oxf) 2011;33:284–91.
crossref pmid
13. Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop 2011;45:15–22.
crossref pmid pmc pdf
14. Venkatesan M, Smith RP, Balasubramanian S, Khan A, Uzoigwe CE, Coats TJ, et al. Serum lactate as a marker of mortality in patients with hip fracture: a prospective study. Injury 2015;46:2201–5.
crossref pmid
15. Davis JW, Sue LP, Dirks RC, Kaups KL, Kwok AM, Wolfe MM, et al. Admission base deficit is superior to lactate in identifying shock and resuscitative needs in trauma patients. Am J Surg 2020;220:1480–4.
crossref pmid
16. Chen X, Zhang J, Zhang Y, Lin Y, Liu Z, Wang X, et al. Serum lactate concentration on admission to hospital predicts the postoperative mortality of elderly patients with hip fractures 30 days after surgery. Am J Transl Res 2021;13:10363–71.
pmid pmc
17. Uzoigwe CE, Venkatesan M, Smith R, Burnand HG, Young PS, Cheesman CL, et al. Serum lactate is a prognostic indicator in patients with hip fracture. Hip Int 2012;22:580–4.
crossref pmid pdf
18. Refaeli E, Zarour S, Lior Y, Herut M, Rabkin V, Aharonov M, et al. Prevalence of preoperative metabolic disturbances in elderly patients with hip fracture and their association with mortality: a retrospective cohort study. J Clin Anesth 2023;88:111137.
crossref pmid
19. Caterino JM, Valasek T, Werman HA. Identification of an age cutoff for increased mortality in patients with elderly trauma. Am J Emerg Med 2010;28:151–8.
crossref pmid
20. Demirel E, Sahin A. Predictive value of blood parameters and comorbidities on three-month mortality in elderly patients with hip fracture. Cureus 2021;13:e18634.
crossref pmid pmc
21. Mattisson L, Bojan A, Enocson A. Epidemiology, treatment and mortality of trochanteric and subtrochanteric hip fractures: data from the Swedish fracture register. BMC Musculoskelet Disord 2018;19:369.
crossref pmid pmc pdf
22. Sterling RS. Gender and race/ethnicity differences in hip fracture incidence, morbidity, mortality, and function. Clin Orthop Relat Res 2011;469:1913–8.
crossref pmid pmc


ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#401 Yuksam Hyundai Venturetel, 20, Teheran-ro 25-gil, Gangnam-gu, Seoul 06132, Korea
Tel: +82-2-2269-1039    Fax: +82-2-2269-1040    E-mail: agmr.editorial@gmail.com                

Copyright © 2024 by Korean Geriatrics Society.

Developed in M2PI

Close layer
prev next